September 7, 2011
Lonza celebrates 40 years as leading producer of vitamin B3
Lonza announced the celebration of its 40th year of Niacin production in Visp, Switzerland, on September 1.
As the world's leading vitamin B3 producer for over four decades, Lonza supplies greater than half the total vitamin B3 demand in the global feed and food industries. To support future growth initiatives, a new vitamin B3 manufacturing facility is slated to open at Lonza's life-sciences campus during the fourth quarter of 2012.
Lonza's Niacin production first began in 1971 in Visp, Switzerland. To support ever-growing global demand and quality requirements, two Niacinamide plants were subsequently constructed. In 1995, Lonza broke ground in Guangzhou, China; while a second plant followed in 2003 in Nansha, China.
"Lonza's multi-site concept, know-how and experience, as well as exceptional quality, service and reliability have enabled us to become the leading partner to support the long-term growth for food formulators and end-use product manufacturers of human and animal nutrition products," said Roman Quinter, head of the Nutrition business unit. "As the global leader in vitamin B3 production, Lonza continues to lead the nutrition industry in product quality and innovation, supported by scientific research."
"Vitamin B3 can be found in all living cells, but it is not produced naturally in the body. It is therefore considered essential and must be supplied to the body through diet or direct supplementation," said Kevin Owen, Ph.D., NAFTA head of technical marketing and scientific affairs at Lonza. "Therefore, niacin is a critical component of the global food and feed industries."
In the feed industry, nutritionists agree that niacin supplementation is required in every swine and poultry diet to meet the body's basal requirement. In 2010, it was estimated that over 18 billion chickens and over 950 million pigs received vitamin B3 supplements in their feed, with most of the Niacin originating from Lonza. As the global leader in the vitamin B3 market, Lonza has initiated a series of new research studies to further define the role that supplemental niacin plays in improving animal health, optimising productivity and increasing economic return for the farmer.
- Lonza plans temporary shutdown of niacin plant in Switzerland
- Lonza increases prices of niacin and niacinamide by 7%
- Lonza increase international price for feed grade niacin
- Lonza states no indication in takeover interest made (Press release)
- Lonza launches new global company website (Press Release)